Watch VideoBiotech company Gilead Sciences released testing results Monday that show certain COVID-19 patients improved after receiving the drug remdesivir.
Nearly 600 hospitalized patients who had moderate pneumonia but did not need oxygen support were randomly assigned to be treated with remdesivir for five days, along...
Gilead Shares Early Results Of Remdesivir Trial In COVID-19 Patients
Newsy
0 shares
1 views
You might like
Related news coverage
11 critical questions about the coronavirus that remain unanswered, 6 months after the first cases were reported
Business Insider
· Experts continue to study the coronavirus as the number of people it infects and kills rises each day.
· Scientists are..
-
NA Proactive news snapshot: Milestone Scientific, BetterLife Pharma, Revive Therapeutics, Matinas BioPharma, Biocept UPDATE …
Proactive Investors
-
NA Proactive news snapshot: Biocept, Globex Mining Enterprises, Q BioMed, ImagineAR UPDATE …
Proactive Investors
-
NA Proactive news snapshot: Group Eleven Resources, Globex Mining Enterprises, BetterLife Pharma, Quantum Computing, GlobeX Data, Naturally Splendid UPDATE …
Proactive Investors
-
NA Proactive news snapshot: Quantum Computing, GlobeX Data, Naturally Splendid, CleanSpark UPDATE …
Proactive Investors
Advertisement
More coverage
Gilead Announces Clinical Trial For An Inhaled Version Of Remdesivir
Newsy
Watch VideoGilead Sciences announced Monday it will start human clinical trials for an inhaled version of remdesivir as a potential..
-
NA Proactive news snapshot: BevCanna Enterprises, Cabral Gold, VR Resources, The Valens Company, Metalla Royalty & Streaming, Namaste Technologies UPDATE …
Proactive Investors
-
NA Proactive news snapshot: Namaste Technologies, Orgenesis, Biocept, Ideanomics UPDATE …
Proactive Investors
-
NA Proactive news snapshot: Mandalay Resources, Canafarma, FSD Pharma, NetCents Technology...
Proactive Investors
-
Coronavirus: What’s happening in the labs of pharma companies worldwide
Proactive Investors